miR-10b Inhibition: A Strategy for Treating Metastatic Breast Cancer
August 28, 2024
“We have developed a nanodrug, termed MN-anti-miR10b, that delivers anti-miR-10b antisense oligomers to cancer cells.” BUFFALO, NY- August 28, 2024 – A new research paper was published in Oncotarget's Volume… read more